Gillian Ivers-Read, EVP of Technical Operations and Chief Regulatory O at Clovis Oncology, holds 293.61K shares in Clovis Oncology (Ticker: CLVSQ), holds 0.00 shares in Bio-Path Holdings (Ticker: BPTH).

See the Hottest Stocks Based on Insider Trading >

Gillian Ivers-Read
Clovis Oncology (CLVSQ)
EVP of Technical Operations and Chief Regulatory O

Ranked #5,318 out of 98,624 Corporate Insiders

Profitable Transactions

4 out of 4 Profitable Transactions

Average Return

+85.80%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

Gillian Ivers-Read does not currently own shares as a corporate insider.

A breakdown of Gillian Ivers-Read's holdings

See the Top Stocks by Insiders

Insider Roles

Bio-Path Holdings
(BPTH)

Director

Roles that Gillian Ivers-Read holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Clovis Oncology
(CLVSQ)

Rating:Informative Sell

Date:Jun 03, 2022 - Jun 03, 2023

Return:+95.80%

The most profitable trade made by Gillian Ivers-Read

See the Latest Stocks Traded by Insiders

Gillian Ivers-Read's Trading History

CLVSQ

Clovis Oncology

Nov 03, 2022

―

Uninformative Buy

3.61K

$4.40K

BPTH

Bio-Path Holdings

―

Director

―

$0.00

List of latest transactions for each holding click on a transaction to see Gillian Ivers-Read's performance on stock

See All Insider Trading from Today

Gillian Ivers-Read insider profile FAQ

What is the percentage of profitable transactions made by Gillian Ivers-Read?

The percentage of profitable transactions made by Gillian Ivers-Read is 100%.

What is the average return per transaction made by Gillian Ivers-Read?

The average return per transaction made by Gillian Ivers-Read is 85.80%.

What stocks does Gillian Ivers-Read hold?

Gillian Ivers-Read holds: CLVSQ, BPTH stocks.

What was Gillian Ivers-Read’s latest transaction?

Gillian Ivers-Read latest transaction was an Uninformative Buy of $3.61K.

What was Gillian Ivers-Read's most profitable transaction?

Gillian Ivers-Read’s most profitable transaction was an Informative Sell of CLVSQ stock on June 3, 2022. The return on the trade was 95.80%.

What is Gillian Ivers-Read's role in Clovis Oncology?

Gillian Ivers-Read's role in Clovis Oncology is EVP of Technical Operations and Chief Regulatory O.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Gillian Ivers-Read Insider Profile

Gillian Ivers-Read Clovis Oncology (CLVSQ)EVP of Technical Operations and Chief Regulatory O